Monlunabant
Product Specifications
CAS Number
2712480-46-9
Synonyms
INV-202, (S) -MRI-1891
SKU
C01902-5mg
Target
Cannabinoid Receptor
Applications
Neuronal Signaling
Additionnal Information
Monlunabant (INV-202, (S) -MRI-1891) is a peripherally acting inverse agonist of the cannabinoid type-1 receptor (CB1R), with the potential to treat respiratory and renal complications associated with metabolic disorders. It improves lung compliance in a mouse model of asthma and reduces renal fibrosis in a streptozotocin-induced diabetic nephropathy mouse model.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881531-100 1x 100 µL
IL3RA / CD123 (Acute Myeloid Leukemia Marker) (IL3RA/1531), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041976-100 1x 100 µL
CD27 (Tumor Necrosis Factor Receptor Superfamily 7) (rLPFS2/1611), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
PKSH030361 50 µg
Recombinant Human CSNK1G1/CKI-gamma 1 Protein (His & GST Tag)
Sign In for Pricing
View Details 